ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,653.00
12.50 (0.76%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  12.50 0.76% 1,653.00 1,654.00 1,655.00 1,655.50 1,634.00 1,638.50 3,351,533 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.76 67.79B

GlaxoSmithKline PLC Director/PDMR Shareholding (7786M)

11/05/2015 11:44am

UK Regulatory


Gsk (LSE:GSK)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Gsk Charts.

TIDMGSK

RNS Number : 7786M

GlaxoSmithKline PLC

11 May 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in interests in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned Executive Director on 8 May 2015:

 
               GSK Deferred Annual Bonus Plan 
 S Dingemans   Exercise of a nil priced option 
                over 34,220 shares and 4,620 
                shares granted on 9 March 2012, 
                both of which vested on 9 March 
                2015 under the GlaxoSmithKline 
                Deferred Annual Bonus Plan. 
                GlaxoSmithKline delivered the 
                net of tax value in shares 
                being 20,585. 
 

The fair market value of an Ordinary Share at the point of exercise on 8 May 2015 was GBP14.72.

The Company and the above-mentioned Executive Director were advised of this transaction on 11 May 2015.

This notification relates to a transaction notified in accordance with paragraph 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

V A Whyte

Company Secretary

11 May 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBFLFFEEFZBBL

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock